Patent · US Active

Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors

US7847104B2 · kind B2 · utility

0Cited by
2References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 13, 2007
Grant dateDec 7, 2010
Priority date
Expiry dateFeb 10, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a process of preparing indazolyl ureas that are useful as antagonists of the vanilloid receptor subtype 1 (VR1).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.